𝔖 Bobbio Scriptorium
✦   LIBER   ✦

CK2 signaling in androgen-dependent and -independent prostate cancer

✍ Scribed by Guixia Wang; Kashif A. Ahmad; Gretchen Unger; Joel W. Slaton; Khalil Ahmed


Publisher
John Wiley and Sons
Year
2006
Tongue
English
Weight
190 KB
Volume
99
Category
Article
ISSN
0730-2312

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Protein serine/threonine kinase casein kinase 2 (CK2) is a key player in cell growth and proliferation but is also a potent suppressor of apoptosis. CK2 has been found to be dysregulated in all the cancers that have been examined, including prostate cancer. Investigations of CK2 signaling in the prostate were originally initiated in this laboratory, and these studies have identified significant functional activities of CK2 in relation to normal prostate growth and to the pathobiology of androgen‐dependent and ‐independent prostate cancer. We present a brief overview of these developments in the context of prostate biology. An important outcome of these studies is the emerging concept that CK2 can be effectively targeted for cancer therapy. J. Cell. Biochem. 99: 382–391, 2006. © 2006 Wiley‐Liss, Inc.


📜 SIMILAR VOLUMES


Androgen signaling and its interactions
✍ Mari Kaarbø; Tove I. Klokk; Fahri Saatcioglu 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 261 KB 👁 1 views

## Abstract Prostate cancer is the most frequently diagnosed non‐skin cancer and the third leading cause of cancer mortality in men. In the initial stages, prostate cancer is dependent on androgens for growth, which is the basis for androgen ablation therapy. However, in most cases, prostate cancer

Androgen receptor action in hormone-depe
✍ Irina U. Agoulnik; Nancy L. Weigel 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 177 KB

## Abstract The importance of androgens and androgen receptors (AR) in primary prostate cancer is well established. Metastatic disease is usually treated with some form of androgen ablation, which is effective for a limited amount of time. The role of AR in prostate cancers that recur despite andro

5α-androstane-3α,17β-diol supports human
✍ Qing Yang; Mark A. Titus; Kar-Ming Fung; Hsueh-Kung Lin 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 323 KB 👁 1 views

## Abstract Androgen and androgen receptor (AR) are involved in growth of normal prostate and development of prostatic diseases including prostate cancer. Androgen deprivation therapy is used for treating advanced prostate cancer. This therapeutic approach focuses on suppressing the accumulation of

Identification of androgen-responsive ge
✍ Rolph Pfundt; Frank Smit; Corine Jansen; Tilly Aalders; Huub Straatman; Walter v 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 124 KB 👁 2 views

## Abstract The vast majority of androgen‐dependent prostate tumors progress toward incurable, androgen‐independent tumors. The identification of androgen‐responsive genes, which are still actively transcribed in the tumors of patients who have undergone androgen ablation, may shed light on the mol

Interaction of IGF signaling and the and
✍ Jennifer D. Wu; Kathy Haugk; Libby Woodke; Peter Nelson; Ilsa Coleman; Stephen R 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 352 KB 👁 2 views

## Abstract The insulin‐like growth factor type I receptor (IGF‐IR) has been suggested to play an important role in prostate cancer progression and possibly in the progression to androgen‐independent (AI) disease. The term AI may not be entirely correct, in that recent data suggest that expression